Filing Details
- Accession Number:
- 0001808805-22-000075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-28 18:17:38
- Reporting Period:
- 2022-06-27
- Accepted Time:
- 2022-06-28 18:17:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1808805 | Nautilus Biotechnology Inc. | NAUT | Laboratory Analytical Instruments (3826) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1856938 | Anna Mowry | C/O Nautilus Biotechnology, Inc. 2701 Eastlake Avenue East Seattle WA 98102 | Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-27 | 5,500 | $2.75 | 39,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 1,250 shares of Common Stock acquired on June 1, 2022 through the Issuer's 2021 Employee Stock Purchase Plan.
Billionaire Hedge Funds
